Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Twinlab chapter 11 motions

This article was originally published in The Tan Sheet

Executive Summary

Approval of "first-day motions" by the U.S. Bankruptcy Court for southern N.Y. will allow Twinlab to "preserve its normal business operations...to the maximum extent possible," company announces Sept. 10. Court also approves motion for Twinlab to access up to $8.8 mil. of a $35 mil. debtor-in-possession facility financed by CIT Group. Funds will assist company in covering costs of operations during chapter 11 process. Twinlab announced plans to file for chapter 11 and sell its assets to IdeaSphere Sept. 4 (1"The Tan Sheet" Sept. 8, 2003, p. 14)...

You may also be interested in...



Twinlab Sells Assets To IdeaSphere, Files For Protection From Creditors

IdeaSphere will acquire all assets of dietary supplement manufacturer Twinlab for $65 mil. following the company's filing for Chapter 11 bankruptcy

Investors Go Berserk For Viking, Putting It Top Of Q1 Winners

The top 10 biggest share price winners and losers in Q1 from Evaluate show the investor frenzy for obesity drugs continues, while companies with governance doubts see shareholders retreat.

EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications

Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS095941

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel